全文获取类型
收费全文 | 11892篇 |
免费 | 8273篇 |
国内免费 | 1306篇 |
专业分类
耳鼻咽喉 | 99篇 |
儿科学 | 517篇 |
妇产科学 | 607篇 |
基础医学 | 1297篇 |
口腔科学 | 188篇 |
临床医学 | 1972篇 |
内科学 | 2184篇 |
皮肤病学 | 122篇 |
神经病学 | 799篇 |
特种医学 | 928篇 |
外国民族医学 | 3篇 |
外科学 | 2887篇 |
综合类 | 996篇 |
一般理论 | 3篇 |
预防医学 | 973篇 |
眼科学 | 693篇 |
药学 | 1236篇 |
中国医学 | 191篇 |
肿瘤学 | 5776篇 |
出版年
2023年 | 713篇 |
2022年 | 1248篇 |
2021年 | 983篇 |
2020年 | 1197篇 |
2019年 | 1079篇 |
2018年 | 2454篇 |
2017年 | 1430篇 |
2016年 | 731篇 |
2015年 | 693篇 |
2014年 | 182篇 |
2013年 | 421篇 |
2012年 | 287篇 |
2011年 | 265篇 |
2010年 | 340篇 |
2009年 | 443篇 |
2008年 | 412篇 |
2007年 | 474篇 |
2006年 | 575篇 |
2005年 | 439篇 |
2004年 | 458篇 |
2003年 | 303篇 |
2002年 | 251篇 |
2001年 | 386篇 |
2000年 | 274篇 |
1999年 | 494篇 |
1998年 | 267篇 |
1997年 | 211篇 |
1996年 | 880篇 |
1995年 | 291篇 |
1994年 | 293篇 |
1993年 | 106篇 |
1992年 | 172篇 |
1991年 | 212篇 |
1990年 | 137篇 |
1989年 | 147篇 |
1988年 | 117篇 |
1987年 | 116篇 |
1986年 | 133篇 |
1985年 | 122篇 |
1979年 | 95篇 |
1977年 | 92篇 |
1975年 | 107篇 |
1974年 | 111篇 |
1973年 | 119篇 |
1972年 | 106篇 |
1971年 | 113篇 |
1970年 | 92篇 |
1969年 | 115篇 |
1968年 | 86篇 |
1966年 | 86篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
31.
Glutathione S-transferase Polymorphisms in Head and Neck Squamous Cell Carcinoma Treated with Chemotherapy and/or Radiotherapy 下载免费PDF全文
Mauricio Pereira ManigliaAnelise RussoPatrícia Matos Biselli-ChicoteJuliana Garcia de Oliveira-CucoloGabriela Helena Rodrigues-Flemingjosé Victor -ManigliaÉrika Cristina PavarinoEny Maria Goloni-Bertollo 《Asian Pacific journal of cancer prevention》2020,21(6):1637-1644
Background/Aim: The Glutathione S-transferases (GSTs) are important carcinogen-metabolizing enzymes. Polymorphisms involved in these enzymes can modulate the development and treatment of head and neck cancer. To investigate the association of GSTs polymorphisms with head and neck cancer and risk factors, clinical-pathological features, and survival time of the patients treated with chemotherapy and/or radiotherapy. Methods: The GST gene polymorphisms were evaluated in 197 cases and 514 controls by PCR-RFLP-Polymerase Chain Reaction Restriction Fragment Length Polymorphism. Results: The GSTP-313 was associated with a decreased risk for HNSCC (p=0.050). The GSTP1 haplotype analysis revealed a higher frequency of the AC and AT haplotypes in the case group than in the control group (p=0.013 and p=0.019, respectively), and the opposite for G-C haplotype (p = 0.015). Yet, the different combinations between the genotypes were associated with an increased risk of cancer. The study showed no association between the polymorphisms and primary tumor site, clinical-pathological characteristics, treatment (chemotherapy and/or radiotherapy) and survival time of the patients. Conclusion: The GST polymorphisms combination showed an increased risk for carcinogenesis, and studies with larger casuistry can contribute to the clarification of the role in individual patient differences for the response to chemotherapy and/or radiotherapy and identify biomarkers of susceptibility. 相似文献
32.
Anti-Oxidant,Anti-Hemolytic Effects of Crataegus aronia Leaves and Its Anti- Proliferative Effect Enhance Cisplatin Cytotoxicity in A549 Human Lung Cancer Cell Line 下载免费PDF全文
Islam OmairiFiras Kobeissy Salam Nasreddine 《Asian Pacific journal of cancer prevention》2020,21(10):2993-3003
Objective: For Arabian traditional medicine, Crataegus aronia syn. Azarolus (L) Bosc. ex DC (Rosaceae) is widely used to treat diabetes, sexual weakness, cardiovascular diseases and cancer. The anti-cancerous and anti-hemolysis effects of the hydroalcoholic extract of this plant have never been investigated before. The present study aims to evaluate the biological activities of the hydroalcoholic extract of Crataegus aronia leaves in combination with cisplatin, one of the most widely employed chemotherapeutics, on A549 human lung cancer cell line. Methods: The anti-oxidant and anti-proliferative activities of leaves, fruits, seeds of C. aronia were investigated by DPPH method and MTT assay; respectively. Cell migration activity was investigated by wound healing and by cell aggregation assays. The effect of C. aronia in inducing cell cycle arrest along with activating cell apoptosis was evaluated by flow cytometry and Western blot assays, respectively. Results: Our results showed that C. aronia leaves (C. aronia L.) had the highest anti-oxidant and anti-proliferative activities. The leaves extract was potent against hemolysis of the human erythrocytes and showed elevated decrease in migration by reducing wound healing migration and by increasing cell aggregation. Finally, C. aronia L. treatment exhibited apoptotic activity on A549 cells by the down-regulation of PARP-1, caspase-3 and Bcl-2 proteins and by increasing the percentage of A549 cells in sub G0 cell cycle. Moreover, the co-treatment of C. aronia L. and cisplatin remarkably sensitised A549 cells to cisplatin. Conclusion: The results suggested that C. aronia L. could be used as a potential treatment against human lung cancer exhibiting minimal side effects on human health. 相似文献
33.
国家癌症中心/国家肿瘤质控中心 《中华放射肿瘤学杂志》2020,29(11):925-931
放疗记录与验证系统(RVS)是一套用于防止医用电子加速器等放疗设备治疗参数设置错误,并且记录所有放疗阶段执行参数的医用计算机软件控制系统。为确保患者的治疗安全,必须对记录与验证系统采取必要的质量控制措施。本指南内容涉及:RVS安装和参数设定过程中的质量控制;RVS的验收测试;RVS在临床使用过程中的持续质量控制;使用RVS过程中的典型错误类型;执行RVS验收测试的具体测试例。 相似文献
34.
目的:探讨三种不同引流方式对食管癌术后颈部吻合口瘘的引流效果。方法:收集从2013年1月到2016年9月在我科行食管癌手术并术后发生颈部吻合口瘘患者,比较入组患者所采用的不同颈部引流方式的优劣。结果:共有83例患者纳入研究,有34例进入A组,行纱布条引流组;28例进入B组,行造瘘袋引流组;21例进入C组,行胃管负压引流组。所有入组患者一般资料和手术资料对比无明显统计学差异(P>0.05)。观察指标对比结果显示,C组患者瘘口愈合时间较其他两组时间短[(15.90±4.18)天vs(14.60±4.41)天vs(9.65±3.80)天],住院时间较其他两组短[(18.10±4.17)天vs(16.20±3.78)天vs(12.30±3.29)天],换药次数较其他两组少[(37.55±8.75)天vs(14.5±3.23)天vs(10.00±2.05)天],抗生素使用时间也较其他组明显减少[(13.10±2.49)天vs(10.85±1.84)天vs(7.20±1.74)天]。结论:颈部放置负压引流有助于食管癌术后颈部吻合口瘘愈合,值得临床推广与进一步研究。 相似文献
35.
目的:分析宣威地区与非宣威地区的肺癌临床流行病学与病理特征。方法:以云南省肿瘤医院(昆明医科大学第三附属医院)2015年3月至2015年5月手术治疗的肺癌患者为研究对象,共295例,收集患者相关信息。将其分为宣威地区、非宣威地区进行统计。对患者的临床资料进行回顾性分析,包含病理类型、年龄、性别、吸烟史等。结果:宣威地区、非宣威地区肺癌患者男女比例为1.19∶1和1.69∶1。宣威地区患者平均年龄为[53.41±8.74(34~85)]岁,中位年龄53岁。非宣威地区肺癌患者平均年龄为[58.68±8.63(38~78)]岁,中位年龄59岁。宣威地区肺癌高发年龄为40~59岁段。宣威地区I期肺癌患者占比、T1期肺癌患者占比、N0期肺癌患者占比均高于非宣威地区。宣威地区男性腺癌鳞癌比远高于非宣威地区,差异有显著统计学意义。结论:宣威地区女性肺癌发病率更高,发病年龄更趋年轻化,腺癌比例高,吸烟与宣威地区男性腺癌高发关系不密切。 相似文献
36.
Recurrent BRCA1 Mutation,but no BRCA2 Mutation,in Vietnamese Patients with Ovarian Carcinoma Detected with Next Generation Sequencing 下载免费PDF全文
Hoang Anh VuNgo Dai PhuLe Thai KhuongPham Huy HoaBui Thi Hong NhuVo Thanh NhanLe Quang ThanhNguyen Duy SinhHoang Thanh ChiNguyen Dang QuanNguyen Trong Binh 《Asian Pacific journal of cancer prevention》2020,21(8):2331-2335
Background: Identification of germline and somatic BRCA1/2 mutations in ovarian cancer is important for genetic counseling and treatment decision making with poly ADP ribose polymerase inhibitors. Unfortunately, data on the frequency of BRCA1/2 mutations in Vietnamese patients are scare. Methods: We aim to explore the occurrence of BRCA1/2 mutations in 101 Vietnamese patients with ovarian cancer including serous (n = 58), endometrioid (n = 14), mucinous (n = 24), and clear cell (n = 5) carcinomas. BRCA1/2 mutations were detected from formalin-fixed parafin-embedded tumor samples using the OncomineTM BRCA Research Assay on Personal Genome Machine Platform with Ion Reporter Software for sequencing data analysis. The presence of pathogenic mutations was confirmed by Sanger sequencing. Results: We found no BRCA2 mutation in the entire cohort. Four types of pathogenic mutations in BRCA1 (Ser454Ter, Gln541Ter, Arg1751Ter, and Gln1779AsnfsTer14) were detected in 8 unrelated patients (7.9%) belonging to serous and endometrioid carcinoma groups. Except for the c.1360_1361delAG (Ser454Ter) mutation in BRCA1 exon 11 that was somatic, the other mutations in exons 11, 20, and 22 were germline. Interestingly, the recurrent Arg1751Ter mutation in BRCA1 exon 20 appeared in 4 patients, suggesting that this is a founder mutation in Vietnamese patients. Conclusion: Mutational analysis of tumor tissue using next generation sequencing allowed the detection of both germline and somatic BRCA1/2 mutations. 相似文献
37.
Matin GhanavatiMehdi MovahedBahram RashidkhaniAfshin RakhshaEhsan Hejazi 《Asian Pacific journal of cancer prevention》2019,20(5):1393-1401
Background and objective: The second most common cancer in men after lung cancer is prostate cancer (PC).Previous studies assessed the association between food items or food groups and the risk of PC, but diet quality indicesare unique approaches to study any relations between diet and disease. Our objective was to investigate the effect ofhealthy eating index (HEI-2010) and Mediterranean-Style Dietary Pattern Score (MSDPS) on PC risk. Methods: Inthis case-control study, we recruited 97 patients with MS and 205 control subjects . Dietary intake was evaluted usinga valid and reliable food frequency questionnaire. The HEI and MSDPS were calculated. Logistic regression was usedto evaluate the relationship between HEI and MSDP scores and PC risk after adjusting the confounders. Results: Incomparison to controls, cases had lower score on HEI (61 vs. 70.07; P< 0.001), and higher score on MSDP (26.20 vs.24.49; P= 0.44). After comparing the highest and the lowest tertile of HEI, we observed a significant decreasing trendin the risk of PC (p for trend<0.001). Conclusion: Our findings suggested that a high quality diet, according to HEI,may decrease the risk of PC. 相似文献
38.
目的:初步探讨自制极简入路通道(PORT)在单孔腹腔镜子宫肌瘤切除术中应用的可行性及安全性。方法:回顾性分析空军军医大学西京医院妇产科于2017年3月至2018年12月共完成的46例单孔腹腔镜子宫肌瘤切除术患者,其中24例使用商品化PORT,22例使用我科自制极简PORT,所有患者均配合使用常规腹腔镜器械顺利完成手术。比较两组患者年龄、体质量数、手术时间、术中出血量、子宫肌瘤直径、术中及术后相关并发症、手术前后血红蛋白差值、术后排气时间、术后疼痛模拟评分、住院时间、术后随访情况等指标。结果:所有患者均顺利完成手术,无中转开腹或增加穿刺孔,无并发症发生。商品化PORT组和自制极简PORT组患者的一般资料具有可比性。手术相关指标包括手术时间[(75±56.9)min vs (74±55.7)min]、术中出血量[(55±67.9)ml vs (56±65.8)ml]、子宫肌瘤直径[(6±2.8)cm vs (6±3.4)cm],两组比较无明显统计学差异(P>0.05)。术后恢复指标包括术后排气时间[(12.6±4.4)h vs (13.5±3.4)h]、术后疼痛模拟评分[(2.1±1.3)分 vs (2.0±1.2)分]、住院时间[(3.4±2.8)d vs (3.5±2.6)d],同样无统计学差异(P>0.05)。两组手术效果相同,但术中使用自制极简PORT几乎不增加耗材。结论:自制极简PORT在单孔腹腔镜子宫肌瘤切除术中的应用安全性好,效果确切,节约成本,值得推广。 相似文献
39.
目的探讨联合检测血清细胞角蛋白19片段(CYFRA21 1)、神经元特异性烯醇化酶(NSE)、癌胚抗原(CEA)、糖类抗原125(CA125)、鳞状上皮细胞癌抗原(SCCA)对肺癌的临床诊断价值。方法选取2018年8月至2019年9月在安徽省胸科医院确诊的肺癌患者109例为肺癌组(腺癌61例,鳞癌30例,小细胞癌18例),肺部良性疾病患者75例为良性肺病组,健康体检者49例为对照组。采用电化学发光法检测各组患者血清中CYFRA21 1、NSE、CEA、CA125及SCCA的表达水平。采用Kruskal Wallis检验、χ2检验比较各组血清CYFRA21 1、NSE、CEA、CA125、SCCA水平和阳性率,采用受试者操作特性曲线(ROC)分析上述5种肿瘤标志物对肺癌的联合诊断价值。结果肺癌组的血清CYFRA21 1、NSE、CEA、CA125、SCCA水平和阳性率明显高于良性肺病组和对照组;腺癌组血清CEA水平高于鳞癌组和小细胞癌组;腺癌组CEA阳性率高于鳞癌组;腺癌组SCCA阳性率高于小细胞癌组;鳞癌组SCCA水平和阳性率高于腺癌组和小细胞癌组;鳞癌组CYFRA21 1水平高于小细胞癌组(P<005);小细胞癌组NSE水平和阳性率高于腺癌组和鳞癌组,差异均有统计学意义(P<005)。ROC曲线显示5种肿瘤标志物联合检测肺癌及不同病理分型肺癌的ROC曲线下面积(AUC)最大。结论肿瘤标志物CYFRA21 1、NSE、CEA、CA125、SCCA在不同病理分型肺癌中的表达各不相同,联合检测对不同病理分型肺癌的临床诊断价值更大。 相似文献
40.
肺癌是目前全球发病率和死亡率均居前列的恶性肿瘤,其中肺鳞癌经手术、放化疗等综合治疗后,其疗效仍不满意。随着分子靶向治疗在肺腺癌中取得了令人瞩目的成果,而肺鳞癌患者中EGFR基因突变及ALK融合基因少见,急需探索新的靶点指导肺鳞癌患者的临床治疗。研究表明,FGFR家族(FGFR1-4)是肺鳞癌中突变频率较高的基因,FGFR基因的激活突变和扩增与肺鳞癌的发生和发展密切相关,同时许多小分子 FGFR 抑制剂在临床应用中已经取得较好的治疗效果。目前,许多FGFR抑制剂治疗肺鳞癌的临床试验也正在进行研究,针对FGFR靶点的基因治疗可为肺鳞癌的治疗提供一种新的策略。本文就FGFR在肺鳞癌的靶向治疗中的最新研究进展进行综述。 相似文献